Overview
With recent CMS reimbursement austerity, some stakeholders believe reductions may continue for 2026, while others expect the pendulum to swing the other way. This critical Deft study will help you prepare for either scenario by offering insights into the MAPD benefits and cost components that seniors value most.
Our research will illuminate major product components — including sensitivity to premium, MOOP, drug deductible, medical deductible, PCP and specialist copays, and more — alongside seniors’ preferences for a litany of supplemental benefits that often drive enrollment.
What's Inside the Study
MA Trade-Offs
Our Adaptive Choice-Based Conjoint model will reveal which major Medicare Advantage design trade‑offs consumers are willing to make based on their utilization history, plan tenure, and common demographics.
Testing Product Combinations
Test a virtually unlimited combination of product investments ahead of the bid to learn which combinations can provide the “greatest bang for your buck,” so you can allocate precious PMPM dollars effectively.
Most Valued Supplemental Benefits
Learn the relative value seniors place on various supplemental benefits, as well as the dollars that are allocated to each.
